Sana Biotechnology Inc (NASDAQ:SANA) — Market Cap & Net Worth
Market Cap & Net Worth: Sana Biotechnology Inc (SANA)
Sana Biotechnology Inc (NASDAQ:SANA) has a market capitalization of $871.05 Million ($871.05 Million) as of August 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9351 globally and #2597 in its home market, demonstrating a -2.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sana Biotechnology Inc's stock price $3.13 by its total outstanding shares 278291590 (278.29 Million). Review total liabilities of Sana Biotechnology Inc to assess the company's total debt and financial obligations.
Sana Biotechnology Inc Market Cap History: 2021 to 2026
Sana Biotechnology Inc's market capitalization history from 2021 to 2026. Data shows change from $4.31 Billion to $871.05 Million (-35.63% CAGR).
Index Memberships
Sana Biotechnology Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.04% | #266 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #991 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.72 Trillion | 0.05% | #155 of 263 |
Weight: Sana Biotechnology Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sana Biotechnology Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sana Biotechnology Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SANA by Market Capitalization
Companies near Sana Biotechnology Inc in the global market cap rankings as of August 1, 2026.
Key companies related to Sana Biotechnology Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Sana Biotechnology Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Sana Biotechnology Inc's market cap moved from $4.31 Billion to $ 871.05 Million, with a yearly change of -35.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $871.05 Million | -23.10% |
| 2025 | $1.13 Billion | +149.69% |
| 2024 | $453.62 Million | -60.05% |
| 2023 | $1.14 Billion | +3.29% |
| 2022 | $1.10 Billion | -74.48% |
| 2021 | $4.31 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Sana Biotechnology Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $871.05 Million USD |
| MoneyControl | $871.05 Million USD |
| MarketWatch | $871.05 Million USD |
| marketcap.company | $871.05 Million USD |
| Reuters | $871.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sana Biotechnology Inc
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary… Read more